Literature DB >> 29054944

Anaesthesia and orphan disease: airway and anaesthetic management in Huntington's disease.

Phuong Thao Nguyen1, Daveena Meeks1, Despoina Liotiri1.   

Abstract

We present a case that highlights the issues surrounding the delivery of a safe general anaesthetic to a patient with Huntington's disease (HD) and bulbar dysfunction. In the case of a 46-year-old patient undergoing laparoscopic percutaneous endoscopic gastrostomy tube insertion, we discuss the rationale behind our chosen method and anaesthetic agents as well as airway issues specific to HD. In a patient whose condition would not allow for an awake fibreoptic intubation, we opted for a modified rapid sequence induction. Special considerations were made with regard to muscle relaxation given the complications associated with inadequate paralysis and reversal in patients with HD. The technique we describe may also apply to other patient categories, such as patients with movement disorders, bulbar dysfunction and dementia. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  anaesthesia; movement disorders (other than parkinsons)

Mesh:

Substances:

Year:  2017        PMID: 29054944      PMCID: PMC5665358          DOI: 10.1136/bcr-2017-221354

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Ultrasound assessment of gastric content and volume.

Authors:  P Van de Putte; A Perlas
Journal:  Br J Anaesth       Date:  2014-06-03       Impact factor: 9.166

2.  Anesthetic management of patients with Huntington disease.

Authors:  Jonathon E Kivela; Juraj Sprung; Peter A Southorn; James C Watson; Toby N Weingarten
Journal:  Anesth Analg       Date:  2010-02-01       Impact factor: 5.108

Review 3.  When the bispectral index (bis) can give false results.

Authors:  Leonardo Teixeira Domingues Duarte; Renato Angelo Saraiva
Journal:  Rev Bras Anestesiol       Date:  2009 Jan-Feb       Impact factor: 0.964

Review 4.  Huntington's disease and Huntington's disease-like syndromes: an overview.

Authors:  Felix Gövert; Susanne A Schneider
Journal:  Curr Opin Neurol       Date:  2013-08       Impact factor: 5.710

5.  Controlled rapid sequence induction and intubation - an analysis of 1001 children.

Authors:  Diego Neuhaus; Achim Schmitz; Andreas Gerber; Markus Weiss
Journal:  Paediatr Anaesth       Date:  2013-06-14       Impact factor: 2.556

Review 6.  Gastric tubes and airway management in patients at risk of aspiration: history, current concepts, and proposal of an algorithm.

Authors:  M Ramez Salem; Arjang Khorasani; Siavosh Saatee; George J Crystal; Mohammad El-Orbany
Journal:  Anesth Analg       Date:  2014-03       Impact factor: 5.108

Review 7.  Huntington's disease: a clinical review.

Authors:  Raymund A C Roos
Journal:  Orphanet J Rare Dis       Date:  2010-12-20       Impact factor: 4.123

8.  Anesthetic management of a patient with Huntington's chorea -A case report-.

Authors:  Jong-Man Kang; Jun-Young Chung; Jin Hee Han; Yung-Suk Kim; Bong Jae Lee; Jae-Woo Yi
Journal:  Korean J Anesthesiol       Date:  2013-03-19

9.  Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults.

Authors:  C Frerk; V S Mitchell; A F McNarry; C Mendonca; R Bhagrath; A Patel; E P O'Sullivan; N M Woodall; I Ahmad
Journal:  Br J Anaesth       Date:  2015-11-10       Impact factor: 9.166

10.  Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records.

Authors:  Stephen J W Evans; Ian Douglas; Michael D Rawlins; Nancy S Wexler; Sarah J Tabrizi; Liam Smeeth
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-12       Impact factor: 10.154

View more
  1 in total

Review 1.  Neuro-Cardio Mechanisms in Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Bethan J Critchley; Mark Isalan; Michal Mielcarek
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.